Kaplan-Meier survival analysis did not show statistically significant effect of either GSTO1 (rs4925) or GSTO2 (rs156697 and rs2297235) polymorphisms on overall survival among ccRCC patients (Figure 1a). This evidence concerns the gene GSTO2 and nonpapillary renal cell carcinoma.